Circulating Tumor HPV DNA in Patients With Stage I and II HPV-Associated Head and Neck Cancer After Surgery

Overview of attention for article published in JAMA Otolaryngology–Head & Neck Surgery, June 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 10 X users

So far, Altmetric has seen 14 X posts from 10 X users, with an upper bound of 12,898 followers.

RT @saskianaegele: We conducted the first prospective study of ctHPVDNA as a prognostic biomarker in stage I and II HPV+OPSCC patients trea…

30 May 2024

Reply Repost Favourite

RT @FadenLab: Pleased to share results from the first prospective study of circulating tumor HPV DNA as a prognostic biomarker in stage I-I…

30 May 2024

Reply Repost Favourite

RT @JAMAOto: Most viewed in the last 7 days from @JAMAOto: Study examines association of posttreatment circulating tumor HPV DNA with resi…

09 May 2024

Reply Repost Favourite

Most viewed in the last 7 days from @JAMAOto: Study examines association of posttreatment circulating tumor HPV DNA with residual disease and 2-year overall survival and recurrence-free survival in patients with HPV-associated head and neck cancer. https

09 May 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.